We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Reforming Food, Drug, and Nutraceutical Regulations to Improve Public Health and Reduce Healthcare Costs
Summary
This paper argues that current food, drug, and nutraceutical regulations need reform to better address the global surge in chronic non-communicable diseases. The study suggests that poor diets, regulatory loopholes, and underfunded public health initiatives are contributing to escalating healthcare costs, and proposes preventive healthcare policy changes to improve public health outcomes.
Neglecting preventive healthcare policies has contributed to the global surge in chronic diseases, increased hospitalizations, declining quality of care, and escalating costs. Non-communicable diseases (NCDs)-notably cardiovascular conditions, diabetes, and cancer-consume over 80% of healthcare expenditure and account for more than 60% of global deaths, which are projected to exceed 75% by 2030. Poor diets, sedentary lifestyles, regulatory loopholes, and underfunded public health initiatives are driving this crisis. Compounding the issue are flawed policies, congressional lobbying, and conflicts of interest that prioritize costly, hospital-based, symptom-driven care over identifying and treating to eliminate root causes and disease prevention. Regulatory agencies are failing to deliver their intended functions. For instance, the U.S. Food and Drug Administration's (FDA) broad oversight across drugs, devices, food, and supplements has resulted in inefficiencies, reduced transparency, and public safety risks. This broad mandate has allowed the release of unsafe drugs, food additives, and supplements, contributing to the rising childhood diseases, the burden of chronic illness, and over-medicalization. The author proposes separating oversight responsibilities: transferring authority over food, supplements, and OTC products to a new Food and Nutraceutical Agency (FNA), allowing the FDA to be restructured as the Drug and Device Agency (DDA), to refocus on pharmaceuticals and medical devices. While complete reform requires Congressional action, interim policy shifts are urgently needed to improve public health. Broader structural changes-including overhauling the Affordable Care Act, eliminating waste and fraud, redesigning regulatory and insurance systems, and eliminating intermediaries are essential to reducing costs, improving care, and transforming national and global health outcomes. The information provided herein can serve as a White Paper to help reform health agencies and healthcare systems for greater efficiency and lower costs in the USA and globally.
Sign in to start a discussion.
More Papers Like This
Food, Agriculture, Environment and Chronic non-communicable diseases: How are they connected?
This review examined the connections between modern diet, agricultural practices, and the rise of chronic non-communicable diseases, arguing that environmental changes since industrialization — including chemical pollutants, microplastics, and nutrient-depleted food systems — have outpaced evolutionary adaptation. The authors called for a food systems approach to reducing chronic disease burden.
Planetary health and non-communicable diseases—A converging global crisis
This review examines the convergence of environmental degradation and the global rise in non-communicable diseases, identifying microplastics as one of several environmental pollutants contributing to cardiovascular disease, diabetes, cancer, and chronic respiratory conditions. The authors argue that addressing plastic pollution is integral to a planetary health approach to disease prevention.
The potential of micro- and nanoplastics to exacerbate the health impacts and global burden of non-communicable diseases
This review presents evidence that micro- and nanoplastics may worsen non-communicable diseases like heart disease, diabetes, and respiratory illness by fueling chronic inflammation in the body. The authors also propose that people already suffering from these diseases may absorb even more microplastics due to their weakened tissue barriers, creating a harmful feedback loop.
Toward an Economic and Environmental Sustainability of the Health Systems of Western Countries
This paper discusses economic and environmental sustainability challenges facing Western health systems, arguing for reforms to reduce inequality and environmental impact. It is a public health policy piece not focused on microplastics.
Microplastics, PFAS, and Pharmaceutical Residues as Emerging Contaminants in the Global Food Chain
This chapter reviews how microplastics, PFAS, and pharmaceutical residues enter the global food chain through industrial discharge, agricultural practices, and environmental runoff, emphasising their persistence and bioaccumulation. It evaluates the human health implications and regulatory challenges of managing these co-occurring emerging contaminants.